Release Date: 12/10/23 08:39 Summary: Update Regarding FOR Discount to NAV Price Sensitive: Yes Download Document 205.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%